Mackenzie Financial
BNTX icon

Mackenzie Financial’s BioNTech BNTX Stock Holding History

Mackenzie Financial’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$488K Buy
5,956
+524
+10% +$49.3K ﹤0.01% 1326
2026
Q1 		$477K Buy
5,432
+947
+21% +$97.3K ﹤0.01% 1219
2025
Q4 		$428K Buy
4,485
+195
+5% +$19.6K ﹤0.01% 1264
2025
Q3 		$418K Buy
4,290
+165
+4% +$17.6K ﹤0.01% 1292
2025
Q2 		$444K Buy
4,125
+372
+10% +$37.6K ﹤0.01% 1266
2025
Q1 		$335K Sell
3,753
-150
-4% -$16.8K ﹤0.01% 1343
2024
Q4 		$445K Sell
3,903
-19,370
-83% -$2.21M ﹤0.01% 1225
2024
Q3 		$2.74M Buy
23,273
+6,207
+36% +$571K ﹤0.01% 660
2024
Q2 		$1.38M Sell
17,066
-13,023
-43% -$1.19M ﹤0.01% 799
2024
Q1 		$2.78M Buy
30,089
+8,215
+38% +$788K ﹤0.01% 669
2023
Q4 		$2.3M Buy
21,874
+16,743
+326% +$1.69M ﹤0.01% 700
2023
Q3 		$558K Buy
5,131
+2,380
+87% +$263K ﹤0.01% 978
2023
Q2 		$298K Buy
2,751
+431
+19% +$48.5K ﹤0.01% 1172
2023
Q1 		$286K Sell
2,320
-6,530
-74% -$897K ﹤0.01% 1203
2022
Q4 		$1.33M Buy
8,850
+691
+8% +$106K ﹤0.01% 736
2022
Q3 		$1.1M Buy
8,159
+3,406
+72% +$521K ﹤0.01% 800
2022
Q2 		$709K Buy
4,753
+3,204
+207% +$490K ﹤0.01% 890
2022
Q1 		$264K Sell
1,549
-1,650
-52% -$277K ﹤0.01% 1173
2021
Q4 		$825K Buy
3,199
+2,137
+201% +$585K ﹤0.01% 940
2021
Q3 		$290K Buy
+1,062
New +$338K ﹤0.01% 1150
2021
Q1 		– Sell
-2,501
Closed -$204K – 1126
2020
Q4 		$204K Buy
+2,501
New +$246K ﹤0.01% 993

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Mackenzie Financial's BNTX Position: Q2 2026 in Review

Mackenzie Financial increased its BioNTech (BNTX) stake by 9.6% in Q2 2026, buying an estimated $49.3K and bringing the position to 5,956 shares worth $488K. The position accounts for ﹤0.01% of the portfolio, ranked #1326.

Mackenzie Financial first reported a position in BNTX in Q4 2020 and has held it in 21 quarters since. The position peaked at $2.78M in Q1 2024. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Mackenzie Financial held 5,956 shares of BioNTech worth $488K as of Q2 2026.
  • Mackenzie Financial bought 524 BioNTech shares in Q2 2026, an estimated $49.3K.
  • BioNTech made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1326 holding.
  • Mackenzie Financial first reported a position in BioNTech in Q4 2020 and has held it in 21 quarters since.
  • Mackenzie Financial's BioNTech position peaked at $2.78M in Q1 2024.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.